RE: Talk Radio Link17 Apr 2020 11:57
Myles McNulty tweet:
It seems like #AVCT had been conservative with its estimates that its reagent would be read by 'end of May'. CEO suggests in today's interview that it could in fact be end April / early May!
The phrase "we will know if.." has obviously spooked some investors.
Just remember:
1) The CEO can't guarantee anything to the market (esp. as its biotech and #AVCT is a PLC);
1) See pp.6-8 of my note as to how AVCT has proved its competency in similar situations (aka Zika virus);
3) Cytiva signing up as a partner already. Would they risk their rep on a dud?